Since 1994, NCARD has created a biobank of patient samples to facilitate research aimed at delivering improved clinical outcomes to people of Western Australia and around the world.
Based at Sir Charles Gairdner Hospital (SCGH), the NCARD Biobank consists of a group of clinicians and scientists dedicated to medical research focused on improving diagnosis and treatment of asbestos related diseases such as mesothelioma, as well as other health conditions. Professor Jenette Creaney manages the Biobank, Professors Bruce Robinson, Gary Lee and Anna Nowak serve as members of the NCARD Biobank Management Committee.
The Biobank has been partially funded by a National Health and Medical Research Council Centre of Research Excellence grant.
Over the past 25 years, 3000 Western Australians have donated blood and urine, as well as surplus effusion and tissue samples to the NCARD Biobank. The biobank has supported over thirty different projects with approximately 10,000 biospecimens prepared from de-identified samples donated for medical research. In addition, around 80 cancer cell lines have been established.